| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041532460 |
| P356 | DOI | 10.1007/S00213-005-0140-2 |
| P698 | PubMed publication ID | 16160878 |
| P50 | author | Jérôme Leprince | Q38544634 |
| Jean Claude do-Rego | Q123124232 | ||
| P2093 | author name string | David Chatenet | |
| Hubert Vaudry | |||
| Jean Costentin | |||
| Elizabeth Scalbert | |||
| Bertrand Naudin | |||
| Camille Le Cudennec | |||
| Marie-Hélène Orta | |||
| P2860 | cites work | Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 |
| Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors | Q24322675 | ||
| Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord | Q24656200 | ||
| Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 | Q24674639 | ||
| Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction | Q28137875 | ||
| Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14 | Q28139196 | ||
| Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions | Q28190334 | ||
| Central effects of urotensin-II following ICV administration in rats | Q28205107 | ||
| Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues | Q28207844 | ||
| Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain | Q28208515 | ||
| The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat | Q28211211 | ||
| Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model | Q28219479 | ||
| Behavioral despair in mice: a primary screening test for antidepressants | Q28258027 | ||
| Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice | Q28277839 | ||
| Cardiovascular effects of urotensin II in different brain areas | Q28577178 | ||
| Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord | Q28579322 | ||
| Central nervous system control of food intake | Q29547439 | ||
| Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 | ||
| Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). | Q30807054 | ||
| Functional neuroimaging studies of depression: the anatomy of melancholia | Q32089512 | ||
| Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. | Q33183600 | ||
| Interacting appetite-regulating pathways in the hypothalamic regulation of body weight | Q33536761 | ||
| A neuroanatomic model for depression | Q33658611 | ||
| Adiposity signals and the control of energy homeostasis | Q34071847 | ||
| Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines | Q34231991 | ||
| Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines | Q34271057 | ||
| Neuroanatomical circuits in depression: implications for treatment mechanisms | Q35655859 | ||
| Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes | Q36404166 | ||
| Physiology and pharmacology of corticotropin-releasing factor | Q36923875 | ||
| Models of inhibition in animal behavior | Q39263360 | ||
| Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes | Q39396237 | ||
| Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? | Q40399317 | ||
| Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey | Q40735770 | ||
| Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse | Q41949285 | ||
| The use of a plus-maze to measure anxiety in the mouse | Q42653714 | ||
| Effect of the chronic ingestion of chlorimipramine and desipramine on the hole board response to acute stresses in male rats | Q43316314 | ||
| Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection | Q44205443 | ||
| Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism | Q44239950 | ||
| Central cardiovascular action of urotensin II in conscious rats | Q44289130 | ||
| Proerectile effects of apomorphine in mice | Q44363749 | ||
| Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction | Q44564935 | ||
| Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. | Q45100855 | ||
| Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. | Q47928974 | ||
| Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents | Q47938344 | ||
| A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia | Q48074434 | ||
| Effect of monoamine precursors on the forced-swimming test in mice | Q48152495 | ||
| Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour | Q48204822 | ||
| The role of corticotropin-releasing factor in depression and anxiety disorders | Q48328352 | ||
| A functional anatomical study of unipolar depression. | Q48433687 | ||
| High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. | Q48743651 | ||
| Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. | Q48877778 | ||
| Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety | Q49052360 | ||
| An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association | Q50796983 | ||
| Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. | Q51083613 | ||
| The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. | Q53770341 | ||
| Validity of head-dipping as a measure of exploration in a modified hole-board | Q67344314 | ||
| Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization | Q71489314 | ||
| Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss | Q71839363 | ||
| Effect of changes in swimming area on results of "behavioral despair test" | Q72620796 | ||
| [Comorbidity of anxiety-depression and its treatment] | Q72663650 | ||
| Mixed anxiety depression. For and against | Q72753161 | ||
| 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity | Q73154073 | ||
| Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives | Q73403316 | ||
| Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord | Q73568813 | ||
| Role of urotensin II in patients on dialysis | Q74531870 | ||
| [The exploration reaction in the mouse. Preliminary note.] | Q79582580 | ||
| Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord | Q80590442 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 103-117 | |
| P577 | publication date | 2005-10-22 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Behavioral effects of urotensin-II centrally administered in mice | |
| P478 | volume | 183 |
| Q37737587 | A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects |
| Q79845785 | Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice |
| Q28260943 | Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes |
| Q92404225 | Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice |
| Q43868528 | Concordant localization of functional urotensin II and urotensin II-related peptide binding sites in the rat brain: Atypical occurrence close to the fourth ventricle. |
| Q35521867 | Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout |
| Q98629482 | Identification and signaling characterization of four urotensin II receptor subtypes in the western clawed frog, Xenopus tropicalis |
| Q33819256 | In search of analgesia: emerging roles of GPCRs in pain. |
| Q52664305 | Promoter methylation and Hoxd4 regulate UII mRNA tissue-specific expression in olive flounder (paralichthys olivaceus). |
| Q37737495 | Role of urotensin II in health and disease |
| Q38533390 | State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells |
| Q36384743 | Urotensin II in invertebrates: from structure to function in Aplysia californica |
| Q45732640 | Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis |
| Q53529593 | Urotensin II upregulates migration and cytokine gene expression in leukocytes of the African clawed frog, Xenopus laevis. |
| Q35221658 | Urotensin-II receptor stimulation of cardiac L-type Ca2+ channels requires the βγ subunits of Gi/o-protein and phosphatidylinositol 3-kinase-dependent protein kinase C β1 isoform. |
Search more.